GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

63 hedge funds and large institutions have $21.5M invested in Galectin Therapeutics in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 12 closing their positions.

Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
22
Reduced
16
Closed
12
Calls
$326K
Puts
$1.15M
Net Calls
-$828K
Net Calls Change
+$717K

Top Buyers

1
CCA
1
Catalyst Capital Advisors
New York
$3.4M
2
Northern Trust
2
Northern Trust
Illinois
$1.04M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$3M
4
ARTA
4
A.R.T. Advisors
New York
$408K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$885K

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
Allianz Asset Management
2
Allianz Asset Management
Germany
$0
3
CAM
3
Cormorant Asset Management
Massachusetts
$2.27M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$0
5
DADC
5
D.A. Davidson & Co
Montana
$601K
Name Market Value Shares Shares
Change 		Shares
Change %
AAM
76
American Asset Management
Florida
$0 84 +84 New
1 2 3
4